Summary

Global Opioid Analgesics Market is valued approximately xxx billion in 2020 and is anticipated to grow with a healthy growth rate of more than xxx over the forecast period 2021-2027. Opioids are well known as the most effective drugs for pain management. Their implementation in chronic pain management is a standard procedure in several countries across the world. Growing incidence of cancer, orthopedic diseases, neuropathic pain and chronic pain among the geriatric population serves as key driver for the market. Increasing expenditure on healthcare and increasing disposable income are some other factors driving the Opioid Analgesics Market. Crocin, a medicine which is available in liquid as well as solid form is manufactured by leading analgesics GlaxoSmithKline Asia Private Limited (GSKAP). World Health Organization (WHO) recommends a three-level ladder approach to pain management, which includes the use of drugs with opioid contents. According to Department of Health, about 40% of adults in New York State suffer from a chronic disease and 23% of the state’s hospitalization is due to chronic diseases. However, to avoid the chances of addiction and overuse, strict regulations are imposed on sales of opioids which may impede the growth of the market over the forecast period of 2021-2027. Also, the increase in popularity of personalized medicine is likely to increase the market growth during the forecast period.

The regional analysis of global Opioid Analgesics Market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading region across the world in terms of market share owing to increasing chronic illnesses and growing consumption of opioids as a pain medication are expected to continue boosting sales of opioid analgesics. Whereas, Asia-Pacific is also anticipated to exhibit highest CAGR over the forecast period 2021-2027. Factors such as increasing utilization of high amounts of opioids for pain management would create lucrative growth prospects for the Opioid Analgesics Market across Asia-Pacific region.

Major market player included in this report are:
Pfizer Inc.
Abbott Laboratories
Janssen Pharmaceuticals, Inc. [Johnson & Johnson]
Novartis AG
Bayer AG
GlaxoSmithKline plc
F. Hoffmann-La Roche AG,
Boehringer Ingelheim International GmbH
Bausch Health Companies Inc.
Sanofi S.A.

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Drug Class
Morphine
Codeine
Fentanyl
Meperidine
Methadone
Tramadol
Oxycodone
Dextromethorphan
Buprenorphine
Others


By Ownership:
Surgical Pain
Cancer Pain
Neuropathic Pain
Other
By Route of Administration:
Oral
Parenteral
Transdermal
Other
By End User:
Hospitals
Retail Pharmacies
Drug Stores
Online Pharmacies
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2018, 2019
Base year – 2020
Forecast period – 2021 to 2027

Target Audience of the Global Opioid Analgesics Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors

ページTOPに戻る

Table of Contents

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2027 (USD Billion)
1.2.1. Opioid Analgesics Market, by Region, 2019-2027 (USD Billion)
1.2.2. Opioid Analgesics Market, by Drug Class, 2019-2027 (USD Billion)
1.2.3. Opioid Analgesics Market, by Route of Administration, 2019-2027 (USD Billion)
1.2.4. Opioid Analgesics Market, by Indication, 2019-2027 (USD Billion)
1.2.5. Opioid Analgesics Market, by End-User, 2019-2027 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Opioid Analgesics Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Opioid Analgesics Market Dynamics
3.1. Opioid Analgesics Market Impact Analysis (2019-2027)
3.1.1. Market Drivers
3.1.1.1. Increasing chronic illnesses
3.1.1.2. Increasing expenditure on healthcare
3.1.2. Market Challenges
3.1.2.1. Strict government policies
3.1.3. Market Opportunities
3.1.3.1. Increase in popularity of personalized medicine
Chapter 4. Global Opioid Analgesics Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model (2018-2027)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
Chapter 5. Global Opioid Analgesics Market, by Drug Class
5.1. Market Snapshot
5.2. Global Opioid Analgesics Market by Drug Class, Performance - Potential Analysis
5.3. Global Opioid Analgesics Market Estimates & Forecasts by Drug Class 2018-2027 (USD Billion)
5.4. Opioid Analgesics Market, Sub Segment Analysis
5.4.1. Morphine
5.4.2. Codeine
5.4.3. Fentanyl
5.4.4. Meperidine
5.4.5. Methadone
5.4.6. Tramadol
5.4.7. Oxycodone
5.4.8. Dextromethorphan
5.4.9. Buprenorphine
5.4.10. Others
Chapter 6. Global Opioid Analgesics Market, by Route of Administration
6.1. Market Snapshot
6.2. Global Opioid Analgesics Market by Route of Administration, Performance - Potential Analysis
6.3. Global Opioid Analgesics Market Estimates & Forecasts by Route of Administration 2018-2027 (USD Billion)
6.4. Opioid Analgesics Market, Sub Segment Analysis
6.4.1. Oral
6.4.2. Parenteral
6.4.3. Transdermal
6.4.4. Other
Chapter 7. Global Opioid Analgesics Market, by Indication
7.1. Market Snapshot
7.2. Global Opioid Analgesics Market by Indication, Performance - Potential Analysis
7.3. Global Opioid Analgesics Market Estimates & Forecasts by Indication 2018-2027 (USD Billion)
7.4. Opioid Analgesics Market, Sub Segment Analysis
7.4.1. Surgical Pain
7.4.2. Cancer Pain
7.4.3. Neuropathic Pain
7.4.4. Other
Chapter 8. Global Opioid Analgesics Market, by End-User
8.1. Market Snapshot
8.2. Global Opioid Analgesics Market by End-User, Performance - Potential Analysis
8.3. Global Opioid Analgesics Market Estimates & Forecasts by End-User 2018-2027 (USD Billion)
8.4. Opioid Analgesics Market, Sub Segment Analysis
8.4.1. Hospitals
8.4.2. Retail Pharmacies
8.4.3. Drug Stores
8.4.4. Online Pharmacies
Chapter 9. Global Opioid Analgesics Market, Regional Analysis
9.1. Opioid Analgesics Market, Regional Market Snapshot
9.2. North America Opioid Analgesics Market
9.2.1. U.S. Opioid Analgesics Market
9.2.1.1. Drug Class breakdown estimates & forecasts, 2018-2027
9.2.1.2. Route of Administration breakdown estimates & forecasts, 2018-2027
9.2.1.3. Indication breakdown estimates & forecasts, 2018-2027
9.2.1.4. End-User breakdown estimates & forecasts, 2018-2027
9.2.2. Canada Opioid Analgesics Market
9.3. Europe Opioid Analgesics Market Snapshot
9.3.1. U.K. Opioid Analgesics Market
9.3.2. Germany Opioid Analgesics Market
9.3.3. France Opioid Analgesics Market
9.3.4. Spain Opioid Analgesics Market
9.3.5. Italy Opioid Analgesics Market
9.3.6. Rest of Europe Opioid Analgesics Market
9.4. Asia-Pacific Opioid Analgesics Market Snapshot
9.4.1. China Opioid Analgesics Market
9.4.2. India Opioid Analgesics Market
9.4.3. Japan Opioid Analgesics Market
9.4.4. Australia Opioid Analgesics Market
9.4.5. South Korea Opioid Analgesics Market
9.4.6. Rest of Asia Pacific Opioid Analgesics Market
9.5. Latin America Opioid Analgesics Market Snapshot
9.5.1. Brazil Opioid Analgesics Market
9.5.2. Mexico Opioid Analgesics Market
9.6. Rest of The World Opioid Analgesics Market

Chapter 10. Competitive Intelligence
10.1. Top Market Strategies
10.2. Company Profiles
10.2.1. Pfizer Inc.
10.2.1.1. Key Information
10.2.1.2. Overview
10.2.1.3. Financial (Subject to Data Availability)
10.2.1.4. Product Summary
10.2.1.5. Recent Developments
10.2.2. Abbott Laboratories
10.2.3. Janssen Pharmaceuticals, Inc. [Johnson & Johnson]
10.2.4. Novartis AG
10.2.5. Bayer AG
10.2.6. GlaxoSmithKline plc
10.2.7. F. Hoffmann-La Roche AG,
10.2.8. Boehringer Ingelheim International GmbH
10.2.9. Bausch Health Companies Inc.
10.2.10. Sanofi S.A.
Chapter 11. Research Process
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes
11.3. Research Assumption